Sorrento Therapeutics (SRNE) Pops on FDA Fast Track Designation
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Sorrento Therapeutics (SRNE) stock is getting a boost on Wednesday after the FDA granted it fast-track designation for SP-103.
The post Sorrento Therapeutics (SRNE) Pops on FDA Fast Track Designation appeared first on InvestorPlace.
More From InvestorPlace